The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
World Sleep 2022 | Augmentation monitoring in RLS
Evi Holzknecht
• 14 Mar 2022
Augmentation is defined as a worsening of restless legs syndrome (RLS) symptoms after starting a dopaminergic medication to treat RLS. Evi Holzknecht, MD, Medical University of Innsbruck, Innsbruck, Austria, describes the benefits of systematic monitoring of augmentation risk factors in RLS. According to Dr. Holzknecht, informing therapy regimens based on screening of patient-reported outcomes could lead to reduced augmentation rates. This interview was recorded at the World Sleep Congress 2022 in Rome, Italy.
